跳至主要内容
临床试验/JPRN-UMIN000053649
JPRN-UMIN000053649尚未招募4 期

Innovative Approaches to Inflammatory Arthritis: Efficacy and Safety of non-invasive transcutaneous auricular vagus nerve stimulation (IA-taVNS) - IA-taVNS

Hokkaido University0 个研究点目标入组 20 人开始时间: 2024年2月19日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients will be excluded from the study if they meet any of the following criteria: Those who have developed acute heart failure, myocardial infarction, pulmonary edema, or acute exacerbation of interstitial pneumonia within the past 3 months. Those with a history of progressive cerebral lesions. Those undergoing vagus nerve stimulation therapy. Those with a history of epilepsy. Those with a history of severe cardiovascular disease. Those with pneumothorax. Those with uncontrollable infections. Those who are pregnant or breastfeeding. Those with a history of skin hypersensitivity and skin reactions to metals or other materials. Those who have difficulty with oral intake. Those with severe renal impairment (estimated glomerular filtration rate (eGFR) less than 30ml/min). Those using a cardiac pacemaker or implantable cardioverter-defibrillator. Those already using a low-frequency therapy device. Others who the principal investigator or co-investigator deems inappropriate as study subjects.

研究者

相似试验

招募中
不适用
prospective, observational registration studyfor women with Inflammatory breast cancerInflammatory Breast Cancer, INFLAME, IBC
NL-OMON28954BOOG (the PI of the study is from University Medical Center Groningen)200
进行中(未招募)
1 期
Comparing the effectiveness of tofacitinib extended release (XR) chronotherapy, morning versus evening dosing, in rheumatoid arthritis (RA) and psoriatic arthritis (PsA) patients from a patient’s, clinical as well as a translational point of view.Rheumatoid arthritis or psoriatic arthritis according to respectively 2010 criteria or CASPAR criteriaMedDRA version: 23.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 21.0Level: LLTClassification code 10037160Term: Psoriatic arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders
EUCTR2021-004131-84-NLErasmus Medical Center84
招募中
4 期
Chronotherapy in Inflammatory Arthritis (ChronIA trial): a randomized controlled trial comparing the effectiveness of morning and evening dosing of tofacitinib extended-releaseInflammatory ArthirtisJoint inflammatoin10013361
NL-OMON52175Erasmus MC, Universitair Medisch Centrum Rotterdam84
已完成
1 期
RA morning stiffness studyRheumatoid arthritis, morning stiffnessD001172Rheumatoid Arthritis
JPRN-jRCTs052210155Shima Yoshihito20
已完成
不适用
Clinical studies aimed to confirm the arthritis reduce the effect of AlcoCare HG-P intakeHealthy
JPRN-UMIN000035610Clinical Creative Corporation42